(Q38213432)

31 August 2017

title

Toll-like receptors and B cells: functions and mechanisms (English)

1 reference

31 August 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847763%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Claire M Buchta

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847763%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

1 August 2014

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847763%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847763%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847763%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

12-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847763%20AND%20SRC:MED&resulttype=core&format=json

The structural biology of Toll-like receptors

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Recognition and signaling by toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Deciphering the complexity of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Cytokine-producing B lymphocytes-key regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor stimulation as a third signal required for activation of human naive B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B cells from periodontal disease patients express surface Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Potentiation of TLR9 responses for human naïve B-cell growth through RP105 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

MyD88 is required for the formation of long-term humoral immunity to virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG drives human transitional B cells to terminal differentiation and production of natural antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Maintenance of serological memory by polyclonal activation of human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B cell intrinsic TLR signals amplify but are not required for humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TRAF5 negatively regulates TLR signaling in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Regulation of B1 cell migration by signals through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG inhibits IgE class switch recombination through suppression of NF kappa B activity, but not through Id2 or Bcl6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

T-bet regulates T-independent IgG2a class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor 7 controls the anti-retroviral germinal center response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The immune response modifier resiquimod mimics CD40-induced B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Role for MyD88 signaling in murine gammaherpesvirus 68 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B Cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Essential roles of K63-linked polyubiquitin-binding proteins TAB2 and TAB3 in B cell activation via MAPKs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Essential function for the kinase TAK1 in innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Enhanced B-cell activation mediated by TLR4 and BCR crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Antigen receptor signals rescue B cells from TLR tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Pyogenic bacterial infections in humans with IRAK-4 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Pyogenic bacterial infections in humans with MyD88 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Oncogenically active MYD88 mutations in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptors and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptors and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The role of toll-like receptors in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Topical imiquimod: mechanism of action and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

New hepatitis B vaccine formulated with an improved adjuvant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

The who, how and where of antigen presentation to B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Generation of human CD40-activated B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Murine model of CD40-activation of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Cutting Edge: Importance of IL-6 and Cooperation between Innate and Adaptive Immune Receptors in Cellular Vaccination with B Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Type I IFN Receptor and the B Cell Antigen Receptor Regulate TLR7 Responses via Distinct Molecular Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Control of B-cell responses by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8523-2

B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner

21 January 2018

1 reference

12 December 2020

The antitumor activity induced by the in vivo administration of activated B cells bound to anti-CD3 monoclonal antibody

1 reference

12 December 2020

Adjuvant activities of immune response modifier R-848: comparison with CpG ODN

1 reference

12 December 2020

BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation

1 reference

12 December 2020

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells

1 reference

12 December 2020

B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides

1 reference

12 December 2020

T cell activation in rheumatoid synovium is B cell dependent

1 reference

12 December 2020

IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.

1 reference

12 December 2020

Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4

1 reference

12 December 2020

Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands

1 reference

12 December 2020

Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner

1 reference

12 December 2020

Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis

1 reference

12 December 2020

RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies

1 reference

12 December 2020

IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease

1 reference

12 December 2020

TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses

1 reference

12 December 2020

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

12 December 2020

Activation of autoreactive B cells by CpG dsDNA

1 reference

12 December 2020

Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus

1 reference

12 December 2020

TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses

1 reference

12 December 2020

B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.

1 reference

12 December 2020

B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus

1 reference

12 December 2020

Polyinosinic Acid Is a Ligand for Toll-like Receptor 3

1 reference

12 December 2020

CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.

1 reference

12 December 2020

TLR4 signaling shapes B cell dynamics via MyD88-dependent pathways and Rac GTPases

1 reference

12 December 2020

Success of HPV vaccination is now a matter of coverage

1 reference

12 December 2020

RP105 is associated with MD-1 and transmits an activation signal in human B cells

1 reference

12 December 2020

B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo

1 reference

12 December 2020

Role of Toll-like receptors in primary Sjögren's syndrome with a special emphasis on B-cell maturation within exocrine tissues

1 reference

12 December 2020

Immunology: Toll-like receptors and antibody responses

1 reference

12 December 2020